首页 > 最新文献

Annals of thoracic surgery short reports最新文献

英文 中文
The Risk of Pretransplant Blood Transfusion for Primary Graft Dysfunction After Lung Transplant 移植前输血对肺移植后原发性移植物功能障碍的风险
Pub Date : 2024-09-01 DOI: 10.1016/j.atssr.2024.02.004

Background

Primary graft dysfunction (PGD) is the leading cause of short- and long-term mortality associated with lung transplantation. The impact of pretransplantation blood transfusions for recipients is not fully elucidated.

Methods

This is a retrospective review of 206 consecutive lung transplantations performed at a single academic center (Northwestern University Feinberg School of Medicine, Chicago, IL) from January 2018 to July 2022. Data on patient characteristics, pretransplantation laboratory values, transfusion requirements, and intraoperative and postoperative outcomes were collected.

Results

PGD grade 3 (PGD 3) occurred in 13.2% of the cohort (n = 28). A total of 33 patients received a blood transfusion within 4 weeks, whereas 21 patients received a blood transfusion a week before their lung transplant. Pretransplantation transfusions were strongly associated with a higher incidence of PGD 3 (48.5% vs 6.9%; P < .001). There was no significant difference in 1-year survival between the pretransplantation transfused group and the nontransfused group (77.7% vs 88.0%; P = .478). The 1year survival was reduced in recipients with PGD 3 compared with recipients without PGD 3 (63.5% vs 89.9%; P = .0012). In univariate analysis, pretransplant and intratransplant predictors of PGD 3 included younger age (P < .01), pretransplant extracorporeal membrane oxygenation (ECMO) use (P < .001), higher lung allocation score (P < .001), coronavirus disease 2019 (COVID-19)–related acute respiratory distress syndrome (P < .01), blood transfusion within 4 weeks (P < .001), longer operative time (P < .001), intratransplant blood transfusion (P < .001), and intratransplant venoarterial ECMO use (P < .001).

Conclusions

Pretransplantation blood transfusions could be associated with a higher rate of PGD. The findings indicated the potential risks of pretransplantation blood transfusions in lung transplant recipients.

背景主要移植物功能障碍(PGD)是肺移植短期和长期死亡的主要原因。方法这是对 2018 年 1 月至 2022 年 7 月期间在一个学术中心(伊利诺伊州芝加哥市西北大学范伯格医学院)进行的 206 例连续肺移植手术的回顾性研究。收集了患者特征、移植前实验室值、输血需求、术中和术后结果等数据。结果13.2%的患者(n = 28)出现PGD 3级(PGD 3)。共有 33 名患者在 4 周内接受了输血,21 名患者在肺移植前一周接受了输血。移植前输血与较高的 PGD 3 发生率密切相关(48.5% vs 6.9%;P < .001)。移植前输血组与未输血组的 1 年存活率无明显差异(77.7% vs 88.0%; P = .478)。与未使用 PGD 3 的受者相比,使用 PGD 3 的受者 1 年存活率降低(63.5% vs 89.9%; P = .0012)。在单变量分析中,移植前和移植内预测 PGD 3 的因素包括年龄较小(P < .01)、移植前使用体外膜肺氧合(ECMO)(P < .001)、肺分配评分较高(P < .001)、冠状病毒病 2019 (COVID-19) 相关急性呼吸窘迫综合征(P < .结论移植前输血可能与较高的 PGD 发生率有关。研究结果表明,肺移植受者移植前输血存在潜在风险。
{"title":"The Risk of Pretransplant Blood Transfusion for Primary Graft Dysfunction After Lung Transplant","authors":"","doi":"10.1016/j.atssr.2024.02.004","DOIUrl":"10.1016/j.atssr.2024.02.004","url":null,"abstract":"<div><h3>Background</h3><p>Primary graft dysfunction (PGD) is the leading cause of short- and long-term mortality associated with lung transplantation. The impact of pretransplantation blood transfusions for recipients is not fully elucidated.</p></div><div><h3>Methods</h3><p>This is a retrospective review of 206 consecutive lung transplantations performed at a single academic center (Northwestern University Feinberg School of Medicine, Chicago, IL) from January 2018 to July 2022. Data on patient characteristics, pretransplantation laboratory values, transfusion requirements, and intraoperative and postoperative outcomes were collected.</p></div><div><h3>Results</h3><p>PGD grade 3 (PGD 3) occurred in 13.2% of the cohort (n = 28). A total of 33 patients received a blood transfusion within 4 weeks, whereas 21 patients received a blood transfusion a week before their lung transplant. Pretransplantation transfusions were strongly associated with a higher incidence of PGD 3 (48.5% vs 6.9%; <em>P</em> &lt; .001). There was no significant difference in 1-year survival between the pretransplantation transfused group and the nontransfused group (77.7% vs 88.0%; <em>P</em> = .478). The 1year survival was reduced in recipients with PGD 3 compared with recipients without PGD 3 (63.5% vs 89.9%; <em>P</em> = .0012). In univariate analysis, pretransplant and intratransplant predictors of PGD 3 included younger age (<em>P</em> &lt; .01), pretransplant extracorporeal membrane oxygenation (ECMO) use (<em>P</em> &lt; .001), higher lung allocation score (<em>P</em> &lt; .001), coronavirus disease 2019 (COVID-19)–related acute respiratory distress syndrome (<em>P</em> &lt; .01), blood transfusion within 4 weeks (<em>P</em> &lt; .001), longer operative time (<em>P</em> &lt; .001), intratransplant blood transfusion (<em>P</em> &lt; .001), and intratransplant venoarterial ECMO use (<em>P</em> &lt; .001).</p></div><div><h3>Conclusions</h3><p>Pretransplantation blood transfusions could be associated with a higher rate of PGD. The findings indicated the potential risks of pretransplantation blood transfusions in lung transplant recipients.</p></div>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772993124001074/pdfft?md5=e228bd8a391b2cec1cb5f20db782354a&pid=1-s2.0-S2772993124001074-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140091688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Direct Insertion of a Dumon Stent Into an Intermediate Bronchus Fistula From the Surgical Field 从手术野将杜蒙支架直接插入中支气管瘘管
Pub Date : 2024-09-01 DOI: 10.1016/j.atssr.2024.04.001

A 54-year-old man underwent right S6 segmentectomy for right lung cancer. After discharge, he presented with fever, hemoptysis, and cough, and computed tomography showed an intermediate bronchus fistula. Because direct closure or bronchoplasty was challenging, a Dumon (Novatech) stent was inserted directly into the fistula from the surgical field and covered with an autologous pericardial patch, pedicled mediastinal fat, and intercostal muscle. The Dumon stent was removed by rigid bronchoscopy 1 year later. For an intermediate bronchus fistula that was difficult to repair by bronchoplasty, a Dumon stent was effective for maintaining bronchial patency and preserving the peripheral lung.

一名 54 岁的男子因患右肺癌接受了右 S6 肺段切除术。出院后,他出现发热、咯血和咳嗽,计算机断层扫描显示出现中间支气管瘘。由于直接闭合或支气管成形术具有挑战性,因此从手术野将 Dumon(Novatech)支架直接插入瘘管,并用自体心包补片、纵隔脂肪和肋间肌覆盖。一年后通过硬质支气管镜取出 Dumon 支架。对于难以通过支气管成形术修复的中间支气管瘘,Dumon 支架能有效保持支气管通畅并保留外周肺。
{"title":"Direct Insertion of a Dumon Stent Into an Intermediate Bronchus Fistula From the Surgical Field","authors":"","doi":"10.1016/j.atssr.2024.04.001","DOIUrl":"10.1016/j.atssr.2024.04.001","url":null,"abstract":"<div><p>A 54-year-old man underwent right S6 segmentectomy for right lung cancer. After discharge, he presented with fever, hemoptysis, and cough, and computed tomography showed an intermediate bronchus fistula. Because direct closure or bronchoplasty was challenging, a Dumon (Novatech) stent was inserted directly into the fistula from the surgical field and covered with an autologous pericardial patch, pedicled mediastinal fat, and intercostal muscle. The Dumon stent was removed by rigid bronchoscopy 1 year later. For an intermediate bronchus fistula that was difficult to repair by bronchoplasty, a Dumon stent was effective for maintaining bronchial patency and preserving the peripheral lung.</p></div>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772993124001815/pdfft?md5=db7d1116accd3b95a7dedb80cbcea970&pid=1-s2.0-S2772993124001815-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140756684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of Pulmonary Artery Dilatation in Lung Cancer Patients With Chronic Obstructive Pulmonary Disease Who Underwent Pulmonary Resection 接受手术的患有慢性阻塞性肺病的肺癌患者肺动脉扩张的意义
Pub Date : 2024-09-01 DOI: 10.1016/j.atssr.2024.03.001

Background

The significance of pulmonary artery (PA) diameter in patients with non-small cell lung cancer (NSCLC) and chronic obstructive pulmonary disease (COPD) who undergo pulmonary resection has not been elucidated.

Methods

Data of 357 patients with NSCLC and COPD who underwent pulmonary resection were retrospectively reviewed. The main PA diameter, determined by preoperative computed tomography, relative to the body surface area (PBR), was used as an index of PA dilatation, and patients were divided into 2 groups using median values. The relationship between the PBR and short- and long-term outcomes was also analyzed.

Results

The mean age was 70.8 years, and 82% of the patients were men. The median main PA diameter was 24 mm (range, 17-43 mm), and the median PBR was 14.5 (range, 10.4-28.6). Lobectomy or more was performed in 276 patients (78%) and sublobar resection in 81 patients (22%). The postoperative complication rates did not differ between the low- and high-PBR groups (33% vs 32%, P = .91). The relapse-free survival (RFS) and overall survival (OS) rates of the low-PBR group were significantly better than those of the high-PBR group (5-year RFS: 76% vs 59%, P = .0003; 5-year OS: 88% vs 72%, P = .0010). A multivariable analysis identified high PBR as a poor prognostic factor for both RFS and OS.

Conclusions

PA dilatation was associated with poor long-term outcomes and was an independent poor prognostic factor for both RFS and OS in NSCLC patients with COPD who underwent pulmonary resection.

背景对接受肺切除术的非小细胞肺癌(NSCLC)和慢性阻塞性肺疾病(COPD)患者的肺动脉(PA)直径的意义尚未阐明。方法回顾性研究了357例接受肺切除术的NSCLC和COPD患者的数据。用术前计算机断层扫描确定的相对于体表面积(PBR)的主肺动脉瓣直径作为肺动脉瓣扩张的指标,并用中位值将患者分为两组。结果平均年龄为 70.8 岁,82% 的患者为男性。主PA直径中位数为24毫米(范围为17-43毫米),PBR中位数为14.5(范围为10.4-28.6)。276名患者(78%)接受了肺叶切除或更多切除术,81名患者(22%)接受了肺叶下切除术。低PBR组和高PBR组的术后并发症发生率没有差异(33% vs 32%,P = .91)。低PBR组的无复发生存率(RFS)和总生存率(OS)明显优于高PBR组(5年RFS:76% vs 59%,P = .0003;5年OS:88% vs 72%,P = .0010)。结论 在接受肺切除术的 COPD NSCLC 患者中,PA 扩张与不良的长期预后有关,是 RFS 和 OS 的独立不良预后因素。
{"title":"Significance of Pulmonary Artery Dilatation in Lung Cancer Patients With Chronic Obstructive Pulmonary Disease Who Underwent Pulmonary Resection","authors":"","doi":"10.1016/j.atssr.2024.03.001","DOIUrl":"10.1016/j.atssr.2024.03.001","url":null,"abstract":"<div><h3>Background</h3><p>The significance of pulmonary artery (PA) diameter in patients with non-small cell lung cancer (NSCLC) and chronic obstructive pulmonary disease (COPD) who undergo pulmonary resection has not been elucidated.</p></div><div><h3>Methods</h3><p>Data of 357 patients with NSCLC and COPD who underwent pulmonary resection were retrospectively reviewed. The main PA diameter, determined by preoperative computed tomography, relative to the body surface area (PBR), was used as an index of PA dilatation, and patients were divided into 2 groups using median values. The relationship between the PBR and short- and long-term outcomes was also analyzed.</p></div><div><h3>Results</h3><p>The mean age was 70.8 years, and 82% of the patients were men. The median main PA diameter was 24 mm (range, 17-43 mm), and the median PBR was 14.5 (range, 10.4-28.6). Lobectomy or more was performed in 276 patients (78%) and sublobar resection in 81 patients (22%). The postoperative complication rates did not differ between the low- and high-PBR groups (33% vs 32%, <em>P</em> = .91). The relapse-free survival (RFS) and overall survival (OS) rates of the low-PBR group were significantly better than those of the high-PBR group (5-year RFS: 76% vs 59%, <em>P</em> = .0003; 5-year OS: 88% vs 72%, <em>P</em> = .0010). A multivariable analysis identified high PBR as a poor prognostic factor for both RFS and OS.</p></div><div><h3>Conclusions</h3><p>PA dilatation was associated with poor long-term outcomes and was an independent poor prognostic factor for both RFS and OS in NSCLC patients with COPD who underwent pulmonary resection.</p></div>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772993124001244/pdfft?md5=bc453a5ca3d467f4ac0ca60aec947fef&pid=1-s2.0-S2772993124001244-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140405398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patients With Hypoplastic Left Heart Syndrome Have a Shorter Superior Vena Cava 左心发育不全综合征患者的上腔静脉较短
Pub Date : 2024-09-01 DOI: 10.1016/j.atssr.2024.01.016

Background

The primary treatment for hypoplastic left heart syndrome (HLHS) is the Fontan pathway, which entails performing the Glenn procedure. We hypothesized that the superior vena cava in patients with HLHS was short. As the length of the superior vena cava influences the Glenn procedure, we compared its length between patients with HLHS and those with other congenital heart diseases.

Methods

Patients with HLHS or its variant, patients with ventricular septal defects (VSD), and patients with pulmonary atresia with intact ventricular septum (PA/IVS)—including critical pulmonary stenosis—were enrolled in this study. The effective superior vena cava ratio (ESCVR), which is defined as the inferior border of the left brachiocephalic vein to the superior surface of the right pulmonary artery/height, was measured.

Results

The median ESVCR of the HLHS, VSD, and PA/IVS patients was 12.54 mm/m, 17.96 mm/m, and 18.46 mm/m, respectively. ESVCR of the HLHS group was significantly smaller than that of the other groups (P = .0013 vs VSD group, P = .0002 vs PA/IVS group).

Conclusions

Patients with HLHS have a relatively short superior vena cava, which may complicate the Glenn procedure.

背景左心发育不全综合征(HLHS)的主要治疗方法是丰坦路径,即实施格伦手术。我们假设 HLHS 患者的上腔静脉较短。由于上腔静脉的长度会影响格伦手术的进行,因此我们比较了HLHS患者和其他先天性心脏病患者的上腔静脉长度。方法本研究招募了HLHS或其变异型患者、室间隔缺损(VSD)患者、肺动脉闭锁伴室间隔完整(PA/IVS)患者(包括重度肺动脉狭窄)。结果 HLHS、VSD 和 PA/IVS 患者的 ESVCR 中位数分别为 12.54 mm/m、17.96 mm/m 和 18.46 mm/m。HLHS 组的 ESVCR 明显小于其他组(P = .0013 vs VSD 组,P = .0002 vs PA/IVS 组)。
{"title":"Patients With Hypoplastic Left Heart Syndrome Have a Shorter Superior Vena Cava","authors":"","doi":"10.1016/j.atssr.2024.01.016","DOIUrl":"10.1016/j.atssr.2024.01.016","url":null,"abstract":"<div><h3>Background</h3><p>The primary treatment for hypoplastic left heart syndrome (HLHS) is the Fontan pathway, which entails performing the Glenn procedure. We hypothesized that the superior vena cava in patients with HLHS was short. As the length of the superior vena cava influences the Glenn procedure, we compared its length between patients with HLHS and those with other congenital heart diseases.</p></div><div><h3>Methods</h3><p>Patients with HLHS or its variant, patients with ventricular septal defects (VSD), and patients with pulmonary atresia with intact ventricular septum (PA/IVS)—including critical pulmonary stenosis—were enrolled in this study. The effective superior vena cava ratio (ESCVR), which is defined as the inferior border of the left brachiocephalic vein to the superior surface of the right pulmonary artery/height, was measured.</p></div><div><h3>Results</h3><p>The median ESVCR of the HLHS, VSD, and PA/IVS patients was 12.54 mm/m, 17.96 mm/m, and 18.46 mm/m, respectively. ESVCR of the HLHS group was significantly smaller than that of the other groups (<em>P</em> = .0013 vs VSD group, <em>P</em> = .0002 vs PA/IVS group).</p></div><div><h3>Conclusions</h3><p>Patients with HLHS have a relatively short superior vena cava, which may complicate the Glenn procedure.</p></div>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772993124001013/pdfft?md5=fe0694061e2015687af370f84876cc67&pid=1-s2.0-S2772993124001013-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140463817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complication Rate of the Nuss Procedure in Adults and Pediatric Patients: National Database Analysis 成人和小儿努斯手术的并发症发生率:全国数据库分析
Pub Date : 2024-09-01 DOI: 10.1016/j.atssr.2024.04.013

Background

Pectus excavatum (PE) is the most common congenital chest wall defect and is characterized by the inward displacement of the sternum and costal cartilages. To date, there are limited data on adult patients undergoing the Nuss procedure for PE. This study aimed to assess the complication rate between the pediatric and adult populations and assess the trends in demographics.

Methods

Retrospective analysis was conducted using a global health care database, TriNetX. Current Procedural Terminology codes (21742, 21743) were used to identify all patients who underwent Nuss procedures in the years 2004 to 2023. The cohort was then subdivided on the basis of age and sex. These patients were assessed for 30-day and 90-day major and minor postoperative complications, as well as acute pain and chronic postoperative pain.

Results

A total of 2843 patients who underwent Nuss repair were identified. Patients aged >18 years had increased hemorrhagic complications (3% vs 0.86% in patients aged <18 years; P < .001) and acute pain (55% in patients aged >18 years vs 39.1% in patients aged <18 years; P < .001). Overall complication rates were 28.48% in female patients and 21.7% in male patients (P = .0014). Female patients had higher rates of respiratory complications (6% vs 2.7% in male patients; P = .001), chronic pain (5.2% in female patients vs 2% in male patients; P < .001), and hemorrhagic complications (6% in female patients vs 0.97% in male patients; P = .0042).

Conclusions

This study suggests that adults with PE experience significantly increased postoperative pain and hemorrhagic complications after the Nuss procedure when compared with the pediatric population. Female patients experience significantly higher complication rates when compared with male patients in all age groups.

背景挖掘性胸廓(PE)是最常见的先天性胸壁缺损,其特点是胸骨和肋软骨向内移位。迄今为止,接受 Nuss 手术治疗 PE 的成年患者数据有限。本研究旨在评估儿童和成人的并发症发生率,并评估人口统计学方面的趋势。方法使用全球医疗数据库 TriNetX 进行回顾性分析。使用当前程序术语代码(21742、21743)识别2004年至2023年接受努斯手术的所有患者。然后根据患者的年龄和性别对其进行细分。对这些患者术后 30 天和 90 天的主要和次要并发症以及急性疼痛和术后慢性疼痛进行了评估。年龄为 18 岁的患者出血并发症(3% 对 0.86%;P< .001)和急性疼痛(55% 对 39.1%;P< .001)增加。女性患者的总体并发症发生率为 28.48%,男性患者为 21.7%(P = .0014)。女性患者的呼吸系统并发症(6% vs 2.7%;P = .001)、慢性疼痛(女性患者 5.2% vs 男性患者 2%;P <;.001)和出血并发症(女性患者 6% vs 男性患者 0.97%;P = .0042)发生率较高。在所有年龄组中,女性患者的并发症发生率明显高于男性患者。
{"title":"Complication Rate of the Nuss Procedure in Adults and Pediatric Patients: National Database Analysis","authors":"","doi":"10.1016/j.atssr.2024.04.013","DOIUrl":"10.1016/j.atssr.2024.04.013","url":null,"abstract":"<div><h3>Background</h3><p>Pectus excavatum (PE) is the most common congenital chest wall defect and is characterized by the inward displacement of the sternum and costal cartilages. To date, there are limited data on adult patients undergoing the Nuss procedure for PE. This study aimed to assess the complication rate between the pediatric and adult populations and assess the trends in demographics.</p></div><div><h3>Methods</h3><p>Retrospective analysis was conducted using a global health care database, TriNetX. Current Procedural Terminology codes (21742, 21743) were used to identify all patients who underwent Nuss procedures in the years 2004 to 2023. The cohort was then subdivided on the basis of age and sex. These patients were assessed for 30-day and 90-day major and minor postoperative complications, as well as acute pain and chronic postoperative pain.</p></div><div><h3>Results</h3><p>A total of 2843 patients who underwent Nuss repair were identified. Patients aged &gt;18 years had increased hemorrhagic complications (3% vs 0.86% in patients aged &lt;18 years; <em>P</em> &lt; .001) and acute pain (55% in patients aged &gt;18 years vs 39.1% in patients aged &lt;18 years; <em>P</em> &lt; .001). Overall complication rates were 28.48% in female patients and 21.7% in male patients (<em>P</em> = .0014). Female patients had higher rates of respiratory complications (6% vs 2.7% in male patients; <em>P</em> = .001), chronic pain (5.2% in female patients vs 2% in male patients; <em>P</em> &lt; .001), and hemorrhagic complications (6% in female patients vs 0.97% in male patients; <em>P</em> = .0042).</p></div><div><h3>Conclusions</h3><p>This study suggests that adults with PE experience significantly increased postoperative pain and hemorrhagic complications after the Nuss procedure when compared with the pediatric population. Female patients experience significantly higher complication rates when compared with male patients in all age groups.</p></div>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772993124001943/pdfft?md5=9824bf48ff929568a99d8fdf564cca72&pid=1-s2.0-S2772993124001943-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142129354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concomitant Tricuspid Valve Surgery With Mitral Valve Surgery for Moderate Tricuspid Regurgitation 三尖瓣手术与二尖瓣手术并用治疗中度三尖瓣反流
Pub Date : 2024-09-01 DOI: 10.1016/j.atssr.2023.12.005

Background

Tricuspid valve surgical procedures (TVS) concomitant with mitral valve (MV) surgical procedures for less than severe tricuspid regurgitation (TR) remains controversial. This study examined the long-term outcomes of patients with moderate or mild to moderate TR undergoing MV surgical procedures with or without TVS.

Methods

Patients with moderate or mild to moderate TR undergoing MV replacement or repair between January 2002 and June 2021 were included. Primary outcomes of reoperation and long-term survival were compared for patients undergoing MV replacement or repair with or without TVS before and after stratifying by mitral disease cause.

Results

The study included 505 patients. Mean age was 69 ± 12.7 years. The Society of Thoracic Surgeons Predicted Risk of Mortality for MV replacement (3.71 vs 4.39; P = .34) and repair (1.73 vs 1.67; P = .84) was similar for patients who did and did not undergo TVS. Operative mortality was similar for replacement (4.2% vs 6.1%; P = .77) or repair (0% vs 0%) with or without TVS. Patients undergoing MV replacement or repair with or without TVS had similar 10-year survival (67.1% vs 73.2% [P = .37]; 68.7% vs 78.8% [P = .052]) and rates of reoperation (2.1% vs 0.8% [P = .69]; 4.9% vs 4.6% [P = .99]). Cox proportional hazards modeling confirmed that TVS did not decrease the risk of death after MV replacement (hazard ratio, 0.839 [0.479-1.467]) or repair (hazard ratio, 0.852 [0.516-1.408]). The findings were unchanged after stratifying by MV disease cause or restricting the analysis to patients with moderate TR only, with no differences in survival or reoperation (all P > .05).

Conclusions

Concomitant TVS for moderate or mild to moderate TR did not improve survival or decrease reoperation. Parameters beyond the degree of TR may aid in surgical decision-making.

背景三尖瓣手术(TVS)与二尖瓣手术(MV)同时治疗轻度三尖瓣反流(TR)仍存在争议。本研究探讨了中度或轻度至中度三尖瓣反流患者在接受二尖瓣手术治疗的同时接受或不接受 TVS 的长期疗效。方法纳入 2002 年 1 月至 2021 年 6 月间接受二尖瓣置换或修复手术的中度或轻度至中度三尖瓣反流患者。比较了根据二尖瓣疾病病因分层前后接受中风置换或修补术并行或不行经皮瓣置换术的患者的再手术和长期生存的主要结果。平均年龄为 69 ± 12.7 岁。胸外科医师学会预测的中风置换术(3.71 vs 4.39;P = .34)和修复术(1.73 vs 1.67;P = .84)死亡率风险在接受和未接受 TVS 的患者中相似。进行或不进行 TVS 的置换术(4.2% vs 6.1%;P = .77)或修复术(0% vs 0%)的手术死亡率相似。接受或未接受 TVS 的中风置换术或修复术患者的 10 年生存率(67.1% vs 73.2% [P = .37];68.7% vs 78.8% [P = .052])和再次手术率(2.1% vs 0.8% [P = .69];4.9% vs 4.6% [P = .99])相似。Cox比例危险模型证实,TVS不会降低中风置换术(危险比为0.839 [0.479-1.467])或修复术(危险比为0.852 [0.516-1.408])后的死亡风险。结论中度或轻度至中度TR患者同时进行TVS并不能提高生存率或减少再手术次数。TR程度以外的参数可能有助于手术决策。
{"title":"Concomitant Tricuspid Valve Surgery With Mitral Valve Surgery for Moderate Tricuspid Regurgitation","authors":"","doi":"10.1016/j.atssr.2023.12.005","DOIUrl":"10.1016/j.atssr.2023.12.005","url":null,"abstract":"<div><h3>Background</h3><p>Tricuspid valve surgical procedures (TVS) concomitant with mitral valve (MV) surgical procedures for less than severe tricuspid regurgitation (TR) remains controversial. This study examined the long-term outcomes of patients with moderate or mild to moderate TR undergoing MV surgical procedures with or without TVS.</p></div><div><h3>Methods</h3><p>Patients with moderate or mild to moderate TR undergoing MV replacement or repair between January 2002 and June 2021 were included. Primary outcomes of reoperation and long-term survival were compared for patients undergoing MV replacement or repair with or without TVS before and after stratifying by mitral disease cause.</p></div><div><h3>Results</h3><p>The study included 505 patients. Mean age was 69 ± 12.7 years. The Society of Thoracic Surgeons Predicted Risk of Mortality for MV replacement (3.71 vs 4.39; <em>P</em> = .34) and repair (1.73 vs 1.67; <em>P</em> = .84) was similar for patients who did and did not undergo TVS. Operative mortality was similar for replacement (4.2% vs 6.1%; <em>P</em> = .77) or repair (0% vs 0%) with or without TVS. Patients undergoing MV replacement or repair with or without TVS had similar 10-year survival (67.1% vs 73.2% [<em>P</em> = .37]; 68.7% vs 78.8% [<em>P</em> = .052]) and rates of reoperation (2.1% vs 0.8% [<em>P</em> = .69]; 4.9% vs 4.6% [<em>P</em> = .99]). Cox proportional hazards modeling confirmed that TVS did not decrease the risk of death after MV replacement (hazard ratio, 0.839 [0.479-1.467]) or repair (hazard ratio, 0.852 [0.516-1.408]). The findings were unchanged after stratifying by MV disease cause or restricting the analysis to patients with moderate TR only, with no differences in survival or reoperation (all <em>P</em> &gt; .05).</p></div><div><h3>Conclusions</h3><p>Concomitant TVS for moderate or mild to moderate TR did not improve survival or decrease reoperation. Parameters beyond the degree of TR may aid in surgical decision-making.</p></div>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772993123003923/pdfft?md5=4d5f89435aea6c23af15104a6914b434&pid=1-s2.0-S2772993123003923-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142129352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality Analysis of Online Resources for Patients Undergoing Coronary Artery Bypass Grafting 冠状动脉旁路移植术患者在线资源质量分析
Pub Date : 2024-09-01 DOI: 10.1016/j.atssr.2023.12.021

Background

Online resources are becoming the primary educational resource for patients. Quality and reliability of websites about coronary artery bypass graft (CABG) procedures are unknown.

Methods

We queried 4 search engines (Google, Bing, Yahoo!, and Dogpile) for the terms coronary artery bypass, coronary artery bypass graft, coronary artery bypass graft surgery, and CABG. The top 30 websites from each were aggregated. After exclusions, 85 websites were graded with the DISCERN instrument, patient-focused criteria, and readability calculators by a 2-reviewer system.

Results

Accessibility was low; 34.1% of websites disclosed authorship, and 23.5% were available in Spanish. Median total score was 55 of 95 (interquartile range [IQR], 44-68); this score varied by website type (P = .048). Professional medical society (median, 76; IQR, 76-76) and governmental agency (median, 69; IQR, 56.6-75.5) scored higher, whereas industry (median, 51.8; IQR, 47.1-56.4) and hospital/health care (median, 49; IQR, 40-61) scored lower. Readability was low, with median Flesch-Kincaid grade level score of 11.1 (IQR, 9.5-12.6) and 75.3% of websites written above eighth-grade reading level.

Conclusions

Accessibility of online patient educational resources for CABG procedures is limited by language and reading level despite being widely available. Quality and reliability of the information offered varied between website types. Improving readability to ensure patients’ understanding and comprehensive decision-making should be prioritized.

背景在线资源正在成为患者的主要教育资源。方法我们在 4 个搜索引擎(谷歌、必应、雅虎和 Dogpile)上搜索了冠状动脉搭桥术、冠状动脉搭桥术、冠状动脉搭桥术手术和 CABG。对每个网站的前 30 个网站进行了汇总。结果可访问性较低;34.1%的网站披露了作者身份,23.5%的网站有西班牙语版本。总分中位数为 55 分(95 分)(四分位数间距 [IQR],44-68);该分数因网站类型而异(P = .048)。专业医学会(中位数,76;IQR,76-76)和政府机构(中位数,69;IQR,56.6-75.5)得分较高,而行业(中位数,51.8;IQR,47.1-56.4)和医院/医疗保健(中位数,49;IQR,40-61)得分较低。可读性较低,Flesch-Kincaid 年级评分中位数为 11.1(IQR, 9.5-12.6),75.3% 的网站文字水平高于八年级阅读水平。不同类型的网站所提供信息的质量和可靠性各不相同。应优先考虑提高可读性,以确保患者理解并做出全面决策。
{"title":"Quality Analysis of Online Resources for Patients Undergoing Coronary Artery Bypass Grafting","authors":"","doi":"10.1016/j.atssr.2023.12.021","DOIUrl":"10.1016/j.atssr.2023.12.021","url":null,"abstract":"<div><h3>Background</h3><p>Online resources are becoming the primary educational resource for patients. Quality and reliability of websites about coronary artery bypass graft (CABG) procedures are unknown.</p></div><div><h3>Methods</h3><p>We queried 4 search engines (Google, Bing, Yahoo!, and Dogpile) for the terms <em>coronary artery bypass</em>, <em>coronary artery bypass graft</em>, <em>coronary artery bypass graft surgery</em>, and <em>CABG</em>. The top 30 websites from each were aggregated. After exclusions, 85 websites were graded with the DISCERN instrument, patient-focused criteria, and readability calculators by a 2-reviewer system.</p></div><div><h3>Results</h3><p>Accessibility was low; 34.1% of websites disclosed authorship, and 23.5% were available in Spanish. Median total score was 55 of 95 (interquartile range [IQR], 44-68); this score varied by website type (<em>P</em> = .048). Professional medical society (median, 76; IQR, 76-76) and governmental agency (median, 69; IQR, 56.6-75.5) scored higher, whereas industry (median, 51.8; IQR, 47.1-56.4) and hospital/health care (median, 49; IQR, 40-61) scored lower. Readability was low, with median Flesch-Kincaid grade level score of 11.1 (IQR, 9.5-12.6) and 75.3% of websites written above eighth-grade reading level.</p></div><div><h3>Conclusions</h3><p>Accessibility of online patient educational resources for CABG procedures is limited by language and reading level despite being widely available. Quality and reliability of the information offered varied between website types. Improving readability to ensure patients’ understanding and comprehensive decision-making should be prioritized.</p></div>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772993124000809/pdfft?md5=3f424b7f330634fddad403ac2f4d8eec&pid=1-s2.0-S2772993124000809-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139879629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pneumonectomy for Osteosarcoma Metastases: Two Compelling Cases With Unique Radiology 骨肉瘤转移的肺切除术:两个具有独特放射学特征的令人信服的病例
Pub Date : 2024-09-01 DOI: 10.1016/j.atssr.2024.01.012

Osteosarcoma, the most common primary bone tumor in young individuals, frequently metastasizes hematogenously to the lungs, necessitating pulmonary metastasectomy as a common surgical procedure. While sublobar and lobar resections are accepted approaches, pneumonectomy is considered a major intervention. In this report, we present 2 intriguing cases of patients who underwent pneumonectomy for pulmonary osteosarcoma metastases, emphasizing the challenges of careful patient selection and surgical planning.

骨肉瘤是年轻人最常见的原发性骨肿瘤,经常血行转移到肺部,因此肺转移切除术是一种常见的外科手术。虽然肺叶下切除术和肺叶切除术是公认的方法,但肺切除术被认为是一种主要的干预措施。在本报告中,我们介绍了两例因肺部骨肉瘤转移而接受肺切除术的患者,强调了谨慎选择患者和制定手术计划所面临的挑战。
{"title":"Pneumonectomy for Osteosarcoma Metastases: Two Compelling Cases With Unique Radiology","authors":"","doi":"10.1016/j.atssr.2024.01.012","DOIUrl":"10.1016/j.atssr.2024.01.012","url":null,"abstract":"<div><p>Osteosarcoma, the most common primary bone tumor in young individuals, frequently metastasizes hematogenously to the lungs, necessitating pulmonary metastasectomy as a common surgical procedure. While sublobar and lobar resections are accepted approaches, pneumonectomy is considered a major intervention. In this report, we present 2 intriguing cases of patients who underwent pneumonectomy for pulmonary osteosarcoma metastases, emphasizing the challenges of careful patient selection and surgical planning.</p></div>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772993124000962/pdfft?md5=05df886cf8470b2b5378ad26e39ae17c&pid=1-s2.0-S2772993124000962-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139965884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repairing Bilateral Coronary-Pulmonary Artery Fistulas During Coronary Artery Bypass Grafting 在冠状动脉旁路移植术中修复双侧冠状动脉-肺动脉瘘
Pub Date : 2024-09-01 DOI: 10.1016/j.atssr.2024.03.002

Coronary-pulmonary artery fistulas (CPAFs) are rare entities that can cause significant left-to-right shunting and complicate routine coronary artery bypass grafting. There are no best practice guidelines and a scarcity of reports regarding concomitant treatment of CPAF with coronary artery disease. We present a case of bilateral CPAFs in a 60-year-old man with symptomatic coronary artery disease treated successfully with coronary artery bypass, epicardial ligation, and transpulmonary closure of CPAF with patch reconstruction. This case highlights the importance of optimal myocardial protection and complete closure of the fistula to prevent risk of coronary steal.

冠状动脉-肺动脉瘘(CPAF)是一种罕见的疾病,可导致严重的左向右分流,并使常规冠状动脉旁路移植手术复杂化。目前还没有最佳实践指南,也很少有关于同时治疗冠状动脉疾病的 CPAF 的报道。我们介绍了一例双侧 CPAF 病例,患者是一名 60 岁的男性,伴有无症状冠状动脉疾病,经冠状动脉搭桥、心外膜结扎和补片重建的跨肺闭合 CPAF 治疗后获得成功。该病例强调了最佳心肌保护和完全关闭瘘管对预防冠状动脉盗血风险的重要性。
{"title":"Repairing Bilateral Coronary-Pulmonary Artery Fistulas During Coronary Artery Bypass Grafting","authors":"","doi":"10.1016/j.atssr.2024.03.002","DOIUrl":"10.1016/j.atssr.2024.03.002","url":null,"abstract":"<div><p>Coronary-pulmonary artery fistulas (CPAFs) are rare entities that can cause significant left-to-right shunting and complicate routine coronary artery bypass grafting. There are no best practice guidelines and a scarcity of reports regarding concomitant treatment of CPAF with coronary artery disease. We present a case of bilateral CPAFs in a 60-year-old man with symptomatic coronary artery disease treated successfully with coronary artery bypass, epicardial ligation, and transpulmonary closure of CPAF with patch reconstruction. This case highlights the importance of optimal myocardial protection and complete closure of the fistula to prevent risk of coronary steal.</p></div>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772993124001256/pdfft?md5=ab10485c2945b582001756a48b6e1f9f&pid=1-s2.0-S2772993124001256-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140407232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-Stage Surgical Approach to Aortoesophageal Fistula After Thoracic Endovascular Aortic Repair 胸腔内血管主动脉修复术后主动脉食管瘘的单阶段手术方法
Pub Date : 2024-09-01 DOI: 10.1016/j.atssr.2023.12.009

Background

The aortoesophageal fistula (AEF) caused by thoracic endovascular aortic repair is a challenging condition. Traditional treatment approaches have been associated with high mortality and morbidity. This study introduces a modified single-stage surgical strategy that aims to optimize outcomes and to reduce the risk of recurrence for AEF.

Methods

Our method involving mediastinal infection clearance, direct esophageal repair, aortic remnant cavity isolation with omental refilling, and aortic reconstruction with a Dacron graft (alongside the native aorta) was applied to all the patients.

Results

None of the patients experienced intraoperative or in-hospital mortality. All 3 patients recovered well and exhibited successful repair and functionality at discharge. Our approach effectively controlled infection, repaired aortic and esophageal defects, and prevented future complications. Our experiences indicate a positive impact of this management strategy.

Conclusions

Our single-stage surgical approach offers a promising solution for AEF after thoracic endovascular aortic repair, enhancing patients' quality of life. It achieves excellent outcomes in infection control and aortic and esophageal repair while avoiding the need for multiple staged surgical procedures.

背景胸腔内血管主动脉修补术导致的主动脉食管瘘(AEF)是一种具有挑战性的疾病。传统的治疗方法死亡率和发病率都很高。本研究介绍了一种改良的单阶段手术策略,旨在优化治疗效果并降低 AEF 的复发风险。结果所有患者均未出现术中或院内死亡。3名患者均恢复良好,出院时显示出成功的修复和功能。我们的方法有效控制了感染,修复了主动脉和食管缺损,并预防了未来的并发症。我们的单阶段手术方法为胸腔内主动脉修补术后的 AEF 提供了一种很有前景的解决方案,提高了患者的生活质量。它在感染控制、主动脉和食管修复方面取得了很好的效果,同时避免了多次分期手术的需要。
{"title":"Single-Stage Surgical Approach to Aortoesophageal Fistula After Thoracic Endovascular Aortic Repair","authors":"","doi":"10.1016/j.atssr.2023.12.009","DOIUrl":"10.1016/j.atssr.2023.12.009","url":null,"abstract":"<div><h3>Background</h3><p>The aortoesophageal fistula (AEF) caused by thoracic endovascular aortic repair is a challenging condition. Traditional treatment approaches have been associated with high mortality and morbidity. This study introduces a modified single-stage surgical strategy that aims to optimize outcomes and to reduce the risk of recurrence for AEF.</p></div><div><h3>Methods</h3><p>Our method involving mediastinal infection clearance, direct esophageal repair, aortic remnant cavity isolation with omental refilling, and aortic reconstruction with a Dacron graft (alongside the native aorta) was applied to all the patients.</p></div><div><h3>Results</h3><p>None of the patients experienced intraoperative or in-hospital mortality. All 3 patients recovered well and exhibited successful repair and functionality at discharge. Our approach effectively controlled infection, repaired aortic and esophageal defects, and prevented future complications. Our experiences indicate a positive impact of this management strategy.</p></div><div><h3>Conclusions</h3><p>Our single-stage surgical approach offers a promising solution for AEF after thoracic endovascular aortic repair, enhancing patients' quality of life. It achieves excellent outcomes in infection control and aortic and esophageal repair while avoiding the need for multiple staged surgical procedures.</p></div>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772993124000056/pdfft?md5=faf1023bd71c495e976282dd8729e5c8&pid=1-s2.0-S2772993124000056-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139637322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of thoracic surgery short reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1